O'Brien Wealth Partners LLC Amgen Inc Transaction History

O'Brien Wealth Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$262.75 - $319.31 $1,313 - $1,596	-5 Reduced 55.56%	4 $1,000
Q1 2024 Apr 18, 2024	SELL	$268.87 - $324.56 $2,957 - $3,570	-11 Reduced 55.0%	9 $2,000
Q4 2023 Jan 25, 2024	BUY	$255.7 - $288.46 $5,114 - $5,769	20 New	20 $5,000
Q1 2020 Apr 03, 2020	SELL	$182.24 - $241.7 $156,726 - $207,862	-860 Closed	0 $0
Q4 2019 Jan 07, 2020	BUY	$189.21 - $243.2 $162,720 - $209,152	860 New	860 $207,000
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $108,467 - $126,616	-608 Closed	0 $0
Q2 2018 Jul 11, 2018	SELL	$166.05 - $186.51 $15,276 - $17,158	-92 Reduced 13.14%	608 $112,000
Q1 2018 Apr 11, 2018	SELL	$169.43 - $198.0 $76,412 - $89,298	-451 Reduced 39.18%	700 $119,000
Q3 2017 Oct 12, 2017	BUY	$167.29 - $191.0 $192,550 - $219,841	1,151	1,151 $215,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of O'Brien Wealth Partners LLC, based on Form 13F filings with the SEC.

Stay updated on O'Brien Wealth Partners LLC with notifications on news.